Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Intraprocedural Hemodynamics During Concomitant Rheocarna Therapy and Maintenance Hemodialysis: Effects of Dialyzer Membrane Type and Circuit Sequence. Local targets link to admitted publications; unresolved targets remain external evidence.
Global Vascular Guidelines on the Management of Chronic Limb‐Threatening Ischemia
10.1016/j.jvs.2019.02.016 · 2019 · External reference
Outcomes Among Patients With End‐Stage Kidney Disease and Chronic Limb‐Threatening Ischemia: A Population‐Based Cohort Study
10.1097/sla.0000000000006566 · 2024 · External reference
Peripheral Arterial Occlusive Disease Is More Prevalent in Patients With Hemodialysis: Comparison With the Findings of Multidetector‐Row Computed Tomography
10.1053/j.ajkd.2006.04.075 · 2006 · External reference
Pathological Analysis of Medial and Intimal Calcification in Lower Extremity Artery Disease: Impact of Hemodialysis
2023 · External reference
Peripheral Artery Disease and Chronic Kidney Disease: Clinical Synergy to Improve Outcomes
10.1053/j.ackd.2014.07.005 · 2014 · External reference
Cardiovascular Disease in Chronic Kidney Disease. A Clinical Update From Kidney Disease: Improving Global Outcomes (KDIGO)
10.1038/ki.2011.223 · 2011 · External reference
Chronic Limb‐Threatening Ischemia in Patients Undergoing Hemodialysis: Epidemiology, Risk Factors, and Outcomes
10.5551/jat.65843 · 2026 · External reference
Association of Wound, Ischemia, and Foot Infection Clinical Stage With Frailty and Malnutrition in Chronic Limb‐Threatening Ischemia Patients Undergoing Endovascular Intervention
10.1177/17085381221076943 · 2023 · External reference
The Effectiveness of Low‐Density Lipoprotein/Fibrinogen Apheresis in Promoting Wound Healing of no‐Option Chronic Limb‐Threatening Ischemia Foot Ulcers With Wound, Ischemia, and Foot Infection (WIfI) Wound Grade 3: A Single‐Center Retrospective Analysis
10.3390/jcm14082589 · 2025 · External reference
Dextran Sulfate Adsorption of LDL (DSAL) and Rheocarna in LDL Apheresis for Chronic Limb‐Threatening Ischemia (CTLI)
2025 · External reference
Efficacy of Rheocarna((R)), a Novel Apheresis Device, in Patients With no‐ or Poor‐Option Chronic Limb‐Threatening Ischemia
10.1253/circj.cj-24-0830 · 2025 · External reference
Correlation Between Bradykinin Concentration and Blood Pressure During Rheocarna Therapy: A Single‐Center Case Series
10.1111/1744-9987.14105 · 2024 · External reference
Transcutaneous Oxygen Tension and Bradykinin Concentration During Rheocarna Therapy: Case Series
10.1111/1744-9987.70067 · 2025 · External reference
Intradialytic Hypotension Is an Important Risk Factor for Critical Limb Ischemia in Patients on Hemodialysis
10.1186/s12882-019-1662-x · 2019 · External reference
An Update Review of Intradialytic Hypotension: Concept, Risk Factors, Clinical Implications and Management
10.1093/ckj/sfaa078 · 2020 · External reference
The Time of Onset of Intradialytic Hypotension During a Hemodialysis Session Associates With Clinical Parameters and Mortality
10.1016/j.kint.2021.01.018 · 2021 · External reference
The Characteristics of Dialysis Membranes: Benefits of the AN69 Membrane in Hemodialysis Patients
10.3390/jcm12031123 · 2023 · External reference
Examination on the Usefulness of a Specific Stacked Dialyzer AN69 Membrane for Microcirculation in Hemodialysis Patients With PAD Complication
2023 · External reference
Therapeutic Effects of the Long‐Term Use of PAN Membrane Dialyzer in Hemodialysis Patients: Efficacy in Old Dialysis Patients With Mild PAD
10.1272/jnms.81.221 · 2014 · External reference
A Crossover Study of the Acrylonitrile‐Co‐Methallyl Sulfonate and Polysulfone Membranes for Elderly Hemodialysis Patients: The Effect on Hemodynamic, Nutritional, and Inflammatory Conditions
10.1097/mat.0b013e31821796f1 · 2011 · External reference
Two Cases Simultaneously Treated With Rheocarna and Hemodialysis
2023 · External reference
Evaluation of the Treatment Volume and Removal Rate of Rheocarna: A Novel Adsorption‐Type Blood Purification Device for Patients With Chronic Limb‐Threatening Ischemia
10.1111/1744-9987.14050 · 2023 · External reference
Investigation of Treatment Volume Versus Circulating Blood Volume During Rheocarna Treatment
10.1111/1744-9987.14117 · 2024 · External reference
Blood Pressure and Volume Management in Dialysis: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
10.1016/j.kint.2020.01.046 · 2020 · External reference
Automatic Control of Blood Volume Trends During Hemodialysis
10.1097/00002480-199407000-00033 · 1994 · External reference
A New Device to Monitor Blood Volume in Hemodialysis Patients
10.1111/j.1744-9987.2010.00845.x · 2010 · External reference
Feasibility of Portable Laser Doppler Flowmeter for Foot Blood Flow Assessment in Patients With Chronic Limb Threatening Ischaemia
10.1016/j.ejvsvf.2025.09.003 · 2025 · External reference
Regional Disparities in Incidence, Therapeutic Approaches, and in‐Hospital Mortality of Critical Limb Ischemia in Japan
10.5551/jat.65621 · 2025 · External reference
Differences in Long‐Term Outcomes in End‐Stage Kidney Disease Patients With Chronic Limb‐Threatening Ischemia
10.1016/j.avsg.2023.05.002 · 2023 · External reference
The Plasma Protein Fibrinogen Stabilizes Clusters of Red Blood Cells in Microcapillary Flows
10.1038/srep04348 · 2014 · External reference
Effects of Different Lipoprotein Apheresis Methods on Serum Protein Levels
10.1016/j.atherosclerosissup.2015.02.018 · 2015 · External reference
Bradykinin and Des‐Arg(9)‐Bradykinin Metabolic Pathways and Kinetics of Activation of Human Plasma
10.1152/ajpheart.2001.281.1.h275 · 2001 · External reference
Inhibition of Aminopeptidase P Potentiates Wheal Response to Bradykinin in Angiotensin‐Converting Enzyme Inhibitor‐Treated Humans
10.1016/s0022-3565(24)35290-5 · 2000 · External reference
Arginine: Its pKa Value Revisited
10.1002/pro.2647 · 2015 · External reference
The Contact Activation and Kallikrein/Kinin Systems: Pathophysiologic and Physiologic Activities
10.1111/jth.13194 · 2016 · External reference
Changes in Bradykinin and Prostaglandins Plasma Levels During Dextran‐Sulfate Low‐Density‐Lipoprotein Apheresis
10.1177/039139889702000310 · 1997 · External reference
Bradykinin in Ischemic Conditioning‐Induced Tissue Protection: Evidences and Possible Mechanisms
10.1016/j.ejphar.2015.10.029 · 2015 · External reference
10.1159/000328961
10.1159/000328961 · 2011 · External reference
Non‐Invasive Assessment of Skin Microvascular Function in Humans: An Insight Into Methods
10.1111/j.1549-8719.2011.00129.x · 2012 · External reference
Effect of Nafamostat Mesilate on Bradykinin Generation and Hemodynamics During LDL Apheresis
10.1111/j.1525-1594.1995.tb02302.x · 1995 · External reference